Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: '7 xylosyltaxol'

Search results for: '7 xylosyltaxol'

Items 11-20 of 176

Page
per page
  1. GS-9620
    A3444 GS-9620
    Target: Toll-like receptors (TLRs)
    Summary: TLR-7 agonist
      insoluble in H2O; ≥20.55 mg/mL
  2. Veliparib dihydrochloride
    A3958 Veliparib dihydrochloride
    Target: PARP
    Summary: PARP-1/PARP-2 inhibitor
      ≥31.7 mg/mL
  3. Fostriecin sodium salt
    A4536 Fostriecin sodium salt
    Target: PP1|PP2A|Topoisomerases|PP4
    Summary: Antitumor antibiotic
      Soluble in H2O
  4. Mitomycin C
    A4452 Mitomycin C
     3 Citation
    Summary: Inhibits DNA synthesis,antibiotic and antitumor agent
      insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL
  5. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    Target: EGFR|ErbB-2
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥24.3 mg/mL
  6. GDC-0941
    A8210 GDC-0941
     10 Citation
    Target: PI3K
    Summary: PI3K inhibitor,potent and selective
      ≥25.7 mg/mL
  7. TAK-632
    A8226 TAK-632
    Target: Raf
    Summary: Pan-RAF inhibitor,potent and selective
      ≥27.75 mg/mL
  8. PD 173074
    A8253 PD 173074
    Target: VEGFR|FGFR
    Summary: FGFR inhibitor
      ≥26.18 mg/mL
  9. Sunitinib malate
    A8255 Sunitinib malate
     2 Citation
    Target: VEGFR
    Summary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
      ≥26.65 mg/mL
  10. GDC-0879
    A5071 GDC-0879
     1 Citation
    Target: Raf
    Summary: B-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL

Items 11-20 of 176

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 166item
  2. Natural Products 3item
  3. Kits 1 item
  4. Lab Reagents 5item
Specificity
  1. Selective 123item
  2. Non-Selective 2item
Reversibility
  1. Reversible 7item
  2. Irreversible 4item
Target
  1. Caspases 2item
  2. Cyclin-Dependent Kinases 5item
  3. Proteasome 4item
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 9item
  6. PI3K 5item
  7. CXCR 1 item
  8. Raf 5item
  9. CSF-1R 1 item
  10. mTOR 1 item
  11. MMP 1 item
  12. Androgen Receptors 1 item
  13. FLT3 2item
  14. GSK-3 2item
  15. Factor Xa 1 item
  16. LPA Receptors 1 item
  17. PLK 1 item
  18. VEGFR 8item
  19. PDGFR 4item
  20. c-Kit 2item
  21. RET 1 item
  22. p38 2item
  23. JNK 1 item
  24. MEK 1 item
  25. FGFR 4item
  26. Nrf2 1 item
  27. Liver X receptors (LXRs) 1 item
  28. Voltage-gated Sodium (NaV) Channels 1 item
  29. Deubiquitinating enzymes (DUBs) 1 item
  30. PP1 1 item
  31. PP2A 1 item
  32. Eukaryotic elongation factors 1 item
  33. Neuraminidases (NA) 1 item
  34. MET 2item
  35. Src 1 item
  36. Trk Receptors 3item
  37. NMDA Receptors 1 item
  38. STAT 1 item
  39. Microtubules/Tubulins 2item
  40. Estrogen and Related Receptors 2item
  41. EGFR 3item
  42. Reverse Transcriptases 1 item
  43. ROCK 2item
  44. BTK 1 item
  45. RIP kinases 1 item
  46. JAK 1 item
  47. HSP90 1 item
  48. Angiotensin AT2 Receptors 1 item
  49. Topoisomerases 5item
  50. Cytochrome P450 (CYP450) 1 item
  51. M3 Receptors 1 item
  52. S6 kinases 1 item
  53. Toll-like receptors (TLRs) 2item
  54. Adenosine Kinases 1 item
  55. Actin 1 item
  56. Serine Proteases 1 item
  57. Survivin 1 item
  58. ERK 1 item
  59. HMG-CoA Reductases 1 item
  60. c-MET 3item
  61. PKC 2item
  62. Calpains 1 item
  63. Ubiquitin-specific proteases 1 item
  64. RAD51 1 item
  65. Trypsins 1 item
  66. HER2 3item
  67. 5-HT2 Receptors 1 item
  68. DGAT 1 item
  69. Insulin and Insulin-like Receptors 1 item
  70. PARP 1 item
  71. CB1 Receptors 1 item
  72. ALK 4item
  73. ROS1 1 item
  74. NK1 Receptors 1 item
  75. Dehydrogenase 1 item
  76. PKG 1 item
  77. PKA 1 item
  78. Myosin light chain kinases (MLCKs) 2item
  79. HIV-1 gp120 1 item
  80. D2 Receptors 1 item
  81. 5-HT1 Receptors 1 item
  82. 5-HT7 Receptors 1 item
  83. 5-HT3 Receptors 1 item
  84. Angiotensin-Converting Enzymes (ACEs) 1 item
  85. Autophagy 1 item
  86. COX 4item
  87. Squalene epoxidases 1 item
  88. GpIIb/IIIa receptor 1 item
  89. Peroxynitrite 1 item
  90. P2X Receptors 1 item
  91. Ron 1 item
  92. Synthases/Synthetases 1 item
  93. Histamine H1 Receptors 1 item
  94. Phospholipases 1 item
  95. Noradrenaline reuptake 1 item
  96. Calcium-Activated Potassium (KCa) Channels 1 item
  97. AChE 1 item
  98. cAMP 1 item
  99. Sulfonylurea receptors 1 item
  100. Peptidoglycan synthesis 1 item
  101. Nuclear Receptors 1 item
  102. Catechol O-Methyltransferase (COMT) 1 item
  103. Angiotensin AT1 Receptors 1 item
  104. Hydroxylases 1 item
  105. DREADD Ligands 1 item
  106. PP4 1 item
  107. AChR 1 item
  108. Fyn kinase 1 item
  109. Ub-conjugating enzyme (E2) complex 1 item
  110. PPAR 1 item
  111. PC-PLC 1 item
  112. Antibiotic 1 item
  113. Hec1 1 item
  114. ErbB-2 1 item
  115. adrenergic receptor 1 item
  116. TRPA 1 item
  117. Histone Acetyltransferases (HATs) 1 item
  118. Tyrosinases 1 item
  119. ITK 1 item
  120. NUAK 1 item
  121. SERT 1 item
  122. prolactin secretion 1 item
  123. gonadotropin release 1 item
  124. 5-HT receptor 1 item
  125. NOP Receptors 1 item
  126. Transferases 1 item
  127. Dopamine receptor 1 item
  128. Histamine receptor 1 item
  129. PRMT 1 item
  130. epoxide hydrolase 1 item
  131. Serotonin (5-HT) reuptake 1 item
  132. NE 1 item
  133. PIKfyve 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 2item
  3. Adrenocortical Carcinoma 1 item
  4. Anesthesia 1 item
  5. Bladder Cancer 2item
  6. B-lymphoid Malignancies 1 item
  7. Brain Injuries Studies 1 item
  8. Breast Cancer 18item
  9. Cancer 81item
  10. Chronic Lymphocytic Leukemia 2item
  11. Cocaine-Related Disorders 1 item
  12. Colon Cancer 8item
  13. Colorectal Cancer 10item
  14. Depression 1 item
  15. Diabetes 3item
  16. Glioblastoma 7item
  17. Glioma 4item
  18. Hepatocellular Carcinoma 3item
  19. HIV 2item
  20. Inflammatory Diseases 2item
  21. Lung Cancer 5item
  22. Lung Carcinoma 2item
  23. Lymphoma 6item
  24. Mantle Cell Lymphoma 2item
  25. Melanoma 7item
  26. Multiple Myeloma 5item
  27. Myeloma 2item
  28. Neuroblastoma 3item
  29. Neurocognitive Disorders 1 item
  30. Non-small Cell Lung Cancer 5item
  31. Obsessive-Compulsive Disorder 1 item
  32. Osteoporosis 1 item
  33. Ovarian Cancer 5item
  34. Pancreatic Cancer 7item
  35. Prostate Cancer 4item
  36. Renal Cancer 1 item
  37. Renal Cell Carcinoma 2item
  38. Rheumatoid Arthritis 1 item
  39. Schizophrenia 2item
  40. Thyroid Cancer 1 item
  41. Type 2 Diabetes 2item